[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:uterine-corpus-adenomyosis":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":31,"states":32},"Uterine Corpus Adenomyosis",3,1,[8,16,24],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07728695","Assessing the Mechanisms and Impact of a Novel Cannabinoid Product for Gynecologic Pain",[12],"Phase 1\u002FPhase 2","RECRUITING","2026-08-26T02:17:41.695983Z","2026-07-30T01:46:14.452649Z",{"nct_id":17,"title":18,"phases":19,"status":21,"updated_at":22,"content_modified":23},"NCT07664956","Cyclobenzaprine for Postoperative Pain in Minimally Invasive Hysterectomy",[20],"Phase 4","NOT_YET_RECRUITING","2026-08-26T02:15:50.539717Z","2026-07-05T03:45:20.356104Z",{"nct_id":25,"title":26,"phases":27,"status":28,"updated_at":29,"content_modified":30},"NCT07120945","Hugo™ Robotic-Assisted Surgery (RAS) System in Gynecological Subjects (Embrace Gynecology)",[],"ACTIVE_NOT_RECRUITING","2026-08-03T03:24:46.343366Z","2026-05-05T02:43:27.676407Z",[],[]]